Literature DB >> 2417078

Cost-effectiveness in oncology.

G J Rees.   

Abstract

Mesh：

Substances：

Year:  1985        PMID： 2417078

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  6 in total

1.  Economic analysis of randomized, controlled trials.

Authors:  G H Lyman
Journal:  Curr Oncol Rep       Date:  2001-09       Impact factor: 5.075

2.  High technology drugs for cancer: the decision process for adding to a formulary.

Authors:  J L Glennie; D M Woloschuk; K W Hall
Journal:  Pharmacoeconomics       Date:  1993-12       Impact factor: 4.981

3.  Fair and effective resource allocation in cancer care: uncharted territory?

Authors:  J A Green; C Williams; A Cribb; B Brecher; M Evans
Journal:  Health Care Anal       Date:  1996-02

4.  Economic analysis of carboplatin versus cisplatin in lung and ovarian cancer.

Authors:  Z M Khan; K L Rascati; J M Koeller
Journal:  Pharmacoeconomics       Date:  1999-07       Impact factor: 4.981

Review 5.  Efficacy and economics of hormonal therapies for advanced breast cancer.

Authors:  Michael S Simon; Dina Ibrahim; Lisa Newman; Miron Stano
Journal:  Drugs Aging       Date:  2002       Impact factor: 3.923

Review 6.  Tracking steps in oncology: the time is now.

Authors:  Juhi M Purswani; Nitin Ohri; Colin Champ
Journal:  Cancer Manag Res       Date:  2018-08-03       Impact factor: 3.989
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.